Highly enriched cardiomyocytes from human embryonic stem cells

Cytotherapy

Volumn 10, Issue 4, 2008, Pages 376-389

  Xu, Qin Xu ^a,b   Zweigerdt, Robert ^a,b   Soo, S Y ^a   Ngoh, Z X ^a   Tham, S C ^a   Wang, S T ^a,b   Graichen, R ^a   Davidson, B ^a   Colman, A ^a,b   Sun, William ^a,c  

^a ES Cell International Pte Ltd   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c Agency for Science   (Singapore)

Author keywords

Arrhythmia; Cardiomyocytes; Cell therapy; Differentiation; Human embryonic stem cells (hESC); QT interval; Safety pharmacology; Selection; Teratoma; Transgenic lines

Indexed keywords

MYOSIN HEAVY CHAIN ALPHA; NEOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SELECTION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TERATOMA; TRANSGENICS; TUMOR GROWTH;

EID: 47249107353     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802105307     Document Type: Article

References (45)

1. Murry, CE, Field, LJ and Menasche, P. (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation, 112, pp. 3174-3183.
2. Leobon, B., Garcin, I. Menasche, P. et al. (2003) Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA, 100, pp. 7808-7811.
3. Balsam, LB, Wagers, AJ Christensen, JL et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428, pp. 668-673.
4. Murry, CE, Soonpaa, MH Reinecke, H. et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428, pp. 664-668.
5. Nygren, JM, Jovinge, S. Breitbach, M. et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med, 10, pp. 494-501.
6. Schroeder, M., Niebruegge, S. Werner, A. et al. (2005) Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng, 92, pp. 920-933.
7. Kehat, I., Khimovich, L. Caspi, O. et al. (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol, 22, pp. 1282-1289.
8. Klug, MG, Soonpaa, MH, Koh, GY and Field, LJ. (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest, 98, pp. 216-224.
9. Kolossov, E., Bostani, T. Roell, W. et al. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med, 203, pp. 2315-2327.
10. Laflamme, MA, Chen, KY Naumova, AV et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnol, 25, pp. 1015-1024.
11. van Laake, LW, Passier, R. Monshouwer-Kloots, J. et al. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res, 1, pp. 9-24.
12. He, JQ, Ma, Y. Lee, Y. et al. (2003) Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res, 93, pp. 32-39.
13. Kehat, I., Kenyagin-Karsenti, D. Snir, M. et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 108, pp. 407-414.
14. Mummery, C., Ward-van Oostwaard, D Doevendans, P. et al. (2003) Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation, 107, pp. 2733-2740.
15. Xu, C., Police, S., Rao, N. and Carpenter, MK. (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res, 91, pp. 501-508.
16. Graichen, R., Xu, QX Braam, SR et al. (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation, 76, pp. 357-370.
17. Passier, R., Oostwaard, DW Snapper, J. et al. (2005) Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells, 23, pp. 772-780.
18. Xu, XQ, Graichen, R. Soo, SY et al. Differentiation
19. Nussbaum, J., Minami, E. Laflamme, MA et al. (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J, 21, pp. 1345-1357.
20. Muller, M., Fleischmann, BK Selbert, S. et al. (2000) Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J, 14, pp. 2540-2548.
21. Huber, I., Itzhaki, I. Caspi, O. et al. (2007) Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J, 21, pp. 2551-2563.
22. Anderson, D., Self, T. Mellor, IR et al. (2007) Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther, 15, pp. 2027-2036.
23. Niebruegge, S., Nehring, A. Baer, H. et al. Cardiomyocyte production in mass suspension culture: Embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Engineering
24. Costa, M., Dottori, M. Sourris, K. et al. (2007) A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc, 2, pp. 792-796.
25. Zwaka, TP and Thomson, JA. (2003) Homologous recombination in human embryonic stem cells. Nat Biotechnol, 21, pp. 319-321.
26. Zweigerdt, R., Burg, M. Willbold, E. et al. (2003) Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: A cell source for new therapies and screening strategies. Cytotherapy, 5, pp. 399-413.
27. Reubinoff, BE, Pera, MF Fong, CY et al. (2000) Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol, 18, pp. 399-404.
28. Costa, M., Dottori, M. Ng, E. et al. (2005) The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods, 2, pp. 259-260.
29. Chuva de Sousa Lopes, SM, Hassink, RJ Feijen, A. et al. (2006) Patterning the heart, a template for human cardiomyocyte development. Dev Dyn, 235, pp. 1994-2002.
30. Small, EM and Krieg, PA. (2004) Molecular regulation of cardiac chamber-specific gene expression. Trends Cardiovasc Med, 14, pp. 13-18.
31. Meyer, T., Boven, KH, Gunther, E. and Fejtl, M. (2004) Micro-electrode arrays in cardiac safety pharmacology: A novel tool to study QT interval prolongation. Drug Saf, 27, pp. 763-772.
32. Weissenburger, J., Davy, JM Chezalviel, F. et al. (1991) Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: Comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. J Pharmacol Exp Ther, 259, pp. 871-883.
33. Reppel, M., Boettinger, C. and Hescheler, J. (2004) Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem, 14, pp. 187-196.
34. Xue, T., Cho, HC Akar, FG et al. (2005) Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers. Circulation, 111, pp. 11-20.
35. Soong, PL, Wang, ST Putti, TC et al.
36. Hidaka, K., Lee, JK Kim, HS et al. (2003) Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J, 17, pp. 740-742.
37. Xu, C., Police, S., Hassanipour, M. and Gold, JD. (2006) Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev, 15, pp. 631-639.
38. Dai, W., Field, LJ Rubart, M. et al. (2007) Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol, 43, pp. 504-516.
39. Leor, J., Gerecht, S. Cohen, S. et al. (2007) Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (Br Card Soc), 93, pp. 1278-1284.
40. Thyagarajan, B., Liu, Y. Shin, S. et al. (2008) Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells, 26, pp. 119-126.
41. Fermini, B. and Fossa, AA. (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov, 2, pp. 439-447.
42. Belardinelli, L., Shryock, JC, Wu, L. and Song, Y. (2005) Use of preclinical assays to predict risk of drug-induced torsades de pointes. Heart Rhythm, 2, p. S16.
43. Zimmermann, WH, Melnychenko, I. Wasmeier, G. et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med, 12, pp. 452-458.
44. Caspi, O., Lesman, A. Basevitch, Y. et al. (2007) Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res, 100, pp. 263-272.
45. Guo, XM, Zhao, YS Chang, HX et al. (2006) Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 113, pp. 2229-2237.